Danaher: Expects 38.5% Increase in 4Q Revenue, Raises Core Revenue Guidance

 Danaher Corp. said it expects its fourth-quarter revenue to rise about 38.5% from the prior year and raised its guidance for core revenue.

The life-sciences conglomerate on Wednesday said it expects core revenue including Cytiva to rise about 15% for the quarter. It previously expected the metric to grow in the low double-digit range.

Rainer Blair, the company's president and chief executive, will comment on financial performance Wednesday at the J.P. Morgan Healthcare Conference at 10:50 a.m. EST, Danaher said. It will report fourth-quarter and year-end results on Jan. 28.

https://www.marketscreener.com/quote/stock/DANAHER-CORPORATION-12295/news/Danaher-Expects-38-5-Increase-in-4Q-Revenue-Raises-Core-Revenue-Guidance-32185990/